MYRIAD GENETICS, INC. (MYGN) Operating income 2016–2025
MYRIAD GENETICS, INC. (MYGN) annual operating income history from SEC filings — each fiscal year as reported.
-$387.2MFY2025 · since FY2016: $153.4M → -$387.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$387.2M | -213.5% |
| FY2024 | -$123.5M | +52.0% |
| FY2023 | -$257.4M | -83.1% |
| FY2022 | -$140.6M | +26.2% |
| FY2021 | -$190.5M | +34.2% |
| FY2020 | -$289.7M | -3911.8% |
| FY2019 | $7.6M | -93.8% |
| FY2018 | $121.9M | +177.0% |
| FY2017 | $44.0M | -71.3% |
| FY2016 | $153.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice